title: Effect of Cnidii Rhizoma on nitric oxide production and invasion of human colorectal adenocarcinoma HT-29 cells.
abstract: Colorectal adenocarcinoma is the most common type of gastrointestinal cancer. Colon adenocarcinoma is a major health problem worldwide due to the high prevalence and mortality rates associated with the disease. The majority of colorectal carcinomas are adenocarcinomas, which originate from the epithelial cells of the colorectal mucosa. HT-29 cells, which originate from human colon adenocarcinoma, are used as anin vitromodel to investigate the effect of malignant transformation on the expression of cellular constituents and functions of the intestinal epithelium. Nitric oxide (NO) is a signaling molecule, which is involved in inflammation and carcinogenesis. It has been reported that enhanced inducible NO synthase (iNOS) activity and the resulting NO concentrations in human colon carcinoma contribute to tumor progression and vascular invasion. The present study investigates the effect of pro-inflammatory cytokine-induced nitric oxide (NO) production and iNOS expression on the invasion of human colorectal adenocarcinoma HT-29 cells, and the effect of extract from Cnidii Rhizoma on NO production and the invasiveness of HT-29 cells. Treatment of HT-29 cells with cytokines, 100 U/ml interferon γ, 10 ng/ml interleukin-1 α and 25 ng/ml tumor necrosis factor α was found to increase NO production. Pretreatment of the cells with Cnidii Rhizoma (0.1-5 mg/ml) resulted in an inhibition of cytokine-induced NO production and iNOS expression. The invasiveness of HT-29 cells through Matrigel was significantly increased by treatment with cytokines. Cnidii Rhizoma inhibited the invasiveness of cytokine-treated HT-29 cells through the Matrigel-coated membrane in a concentration-dependent manner. Matrix metalloproteinase (MMP) activity in HT-29 cells increased following the treatment with cytokines, and pretreatment of the cells with Cnidii Rhizoma inhibited cytokine-induced MMP-2 activity. These results provide sufficient information for the further development of Cnidii Rhizoma as an antitumor metastatic agent for the treatment of colon cancer.
authors.affiliation: Department of Pharmacology, College of Medicine, Dongguk University, Gyeongju, Gyeongsangbuk-do 780-714, Republic of Korea.
authors.forename: Kyung-Soo
authors.initials: KS
authors.lastname: Nam
authors.affiliation: Bio-Medical Research Institute, Kyungpook National University Hospital, Daegu 700-721, Republic of Korea.
authors.forename: Byung Geun
authors.initials: BG
authors.lastname: Ha
authors.affiliation: Bio-Medical Research Institute, Kyungpook National University Hospital, Daegu 700-721, Republic of Korea.
authors.forename: Yun-Hee
authors.initials: YH
authors.lastname: Shon
keywords: Cnidii Rhizoma; colorectal adenocarcinoma HT-29 cells; invasion; matrix metalloproteinase-2; nitric oxide; pro-inflammatory cytokines